Beyond Single-Gene Testing
Most common diseases — heart disease, type 2 diabetes, many cancers — are not caused by a single genetic mutation like classic hereditary conditions, but arise from the combined small effects of hundreds or thousands of genetic variants interacting with lifestyle and environment. Polygenic risk scores attempt to capture this complexity by aggregating the effects of many variants into a single score estimating an individual relative genetic risk for a given condition.
What They Can Offer
For some conditions, polygenic risk scores can meaningfully stratify risk, identifying individuals whose genetic risk is substantially elevated or reduced compared to average, information that could inform earlier or more intensive screening, lifestyle counseling, or preventive intervention for those at highest genetic risk. This represents a potentially valuable complement to traditional risk factors like family history and clinical measurements.
Significant Current Limitations
Polygenic risk scores currently have real limitations: they have been developed and validated predominantly in populations of European ancestry, performing less reliably in other populations, which raises equity concerns about who benefits from this technology. The scores also provide probabilistic rather than deterministic information, and their clinical utility for guiding individual decisions is still being established through ongoing research. They are a promising but immature tool. Research facilities can source lab supplies and diagnostic equipment from our catalog.
